1. Pérez-García, Jésica, Martel-Martel, Abel, García-Vallés, Paula, Perea, José, González-Sarmiento, Rogelio. 2022. Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration. In Cancers, 14, . doi:10.3390/cancers14164029. https://pubmed.ncbi.nlm.nih.gov/36011023/
2. Guo, Jingyan, You, Linya, Zhou, Yu, Chen, Yan, Zhang, Ming. . Spatial enrichment and genomic analyses reveal the link of NOMO1 with amyotrophic lateral sclerosis. In Brain : a journal of neurology, 147, 2826-2841. doi:10.1093/brain/awae123. https://pubmed.ncbi.nlm.nih.gov/38643019/
3. Zhang, Qi, Li, Fei, Li, Tingting, Wang, Xu, Li, Qiang. 2024. Nomo1 deficiency causes autism-like behavior in zebrafish. In EMBO reports, 25, 570-592. doi:10.1038/s44319-023-00036-y. https://pubmed.ncbi.nlm.nih.gov/38253686/
4. Gao, Wen-Long, Liu, Ming, Yang, Yanyan, Peng, Chun, Wang, Yan-Ling. 2012. The imprinted H19 gene regulates human placental trophoblast cell proliferation via encoding miR-675 that targets Nodal Modulator 1 (NOMO1). In RNA biology, 9, 1002-10. doi:10.4161/rna.20807. https://pubmed.ncbi.nlm.nih.gov/22832245/
5. Xing, Wang, Li, Tiangang, Wang, Yixuan, Ai, Chencheng, Tang, Hanbo. 2020. MiR-33a-5p targets NOMO1 to modulate human cardiomyocyte progenitor cells proliferation and differentiation and apoptosis. In Journal of receptor and signal transduction research, 41, 476-487. doi:10.1080/10799893.2020.1825492. https://pubmed.ncbi.nlm.nih.gov/33054489/